Family Office of America, Inc. (FOFA): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$262.2K
Year ended 2025-12-31
$195.5K
Trailing 12 months to 2026-06-30
2021-12-31: -$792.8K2022-12-31: -$558.4K2023-12-31: -$76.5K2024-12-31: -$89.4K2025-12-31: -$262.2K-$262.2K
2021-12-31 Operating Cash Flow (USD) 2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$262.2Kn/m2026-04-16, From 2025-01-01
2024-12-31-$89.4Kn/m2026-04-16, From 2024-01-01
2023-12-31-$76.5Kn/m2025-03-10, From 2023-01-01
2022-12-31-$558.4Kn/m2024-07-18, From 2022-01-01
2021-12-31-$792.8Kn/a2023-04-24, From 2021-01-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Family Office of America, Inc. (FOFA)2025-12-31-$262.2Kn/m
QTREX Quantum Ltd. (QTEX)2025-12-31-$9.86Mn/m
Pulse Biosciences, Inc. (PLSE)2025-12-31-$54.12Mn/m
Co-Diagnostics, Inc. (CODX)2025-12-31-$29.14Mn/m
Harvard Apparatus Regenerative Technology, Inc. (HRGN)2025-12-31-$3.83Mn/m
Vivos Inc (RDGL)2025-12-31-$2.06Mn/m
Catheter Precision, Inc. (VTAK)2025-12-31-$8.30Mn/m
Sintx Technologies, Inc. (SINT)2025-12-31-$8.57Mn/m
RenovoRx, Inc. (RNXT)2025-12-31-$10.97Mn/m

Compare FOFA, QTEX, PLSE, CODX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗